Serum type III procollagen in children with hepatoblastoma.
Pitkänen
S
S
Department of Dermatology, University of Helsinki, Finland.
Perkkiö
M
M
Heikinheimo
M
M
D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood; D018395:CA-19-9 Antigen / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D018197:Hepatoblastoma / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D008297:Male; D010446:Peptide Fragments / Q000097:blood*; D011347:Procollagen / Q000097:blood*; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D010446:Peptide Fragments; D011347:Procollagen; D000509:alpha-Fetoproteins; C041876:procollagen Type III-N-terminal peptide